TY - JOUR
T1 - Swept-source optical coherence tomography angiography vitreo-retinal segmentation in proliferative diabetic retinopathy
AU - Papayannis, Alessandro
AU - Tsamis, Emmanouil
AU - Stringa, Francesco
AU - Iacono, Pierluigi
AU - Battaglia Parodi, Maurizio
AU - Stanga, Paulo Eduardo
N1 - Funding Information:
Acknowledgments to the Manchester Eye Hospital and Manchester Vision Regeneration (MVR) at NIHR/Wellcome Trust Manchester Clinical Research Facility, Central Manchester University Hospital NHS Foundation Trust, Manchester, where Prof P. E. Stanga, A. Papayannis, F. Stringa and E. Tsamis were employed during the period that this research was conducted. The research for this paper was also supported by the Italian Ministry of Health and Fondazione Roma.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was partially facilitated by
Publisher Copyright:
© The Author(s) 2020.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/7/28
Y1 - 2020/7/28
N2 - Purpose: To identify a new cortical vitreous segmentation protocol for non invasive standardised investigation of Neovascularisation (NV) with detection of regression of NV activity in Proliferative Diabetic Retinopathy (PDR). Design: Retrospective study. Participants: One hundred and eighty-six eyes of 93 consecutive diabetic patients (mean age: 52.6 ± 11.0 years) imaged using Topcon Triton® Swept-Source Optical Coherence Tomography Angiography (SS-OCTA) from June 2015 to January 2017. Methods: Scans were performed through the macula, optic disc and areas of possible NV in mid-peripheral retina using 6 × 6 mm and/or 9 × 9 mm raster-patterns in three segmentation protocols: Vitreo-Retinal (VRS), Outer-Vitreous (OVS) and Core-Vitreous Segmentation (CVS). Any suspicion of PDR was confirmed in all patients by Heidelberg® Widefield-Fundus-Fluorescein-Angiography (WF-FFA) and/or Optos® Ultra-WF-FFA (UWF-FFA). Inter-observer reproducibility of NV diagnosis and agreement between SS-OCTA and UWF-FFA were assessed. Primary outcome was the identification of an effective and reproducible segmentation protocol. Secondary outcome was the identification of NV regression after treatment. Results: Sensitivity-specificity reached, respectively, the value of 100 to 100 in detecting NVD, and 96.6 to 100 in detecting NVE in compared areas. SS-OCTA was able to confirm absence of blood flow within the residual NV plexus when using VRS protocol in 30 eyes in which regression of NV with absence of leakage was documented on FFA. Conclusion: Three segmentation protocols (VRS, OVS and CVS) with different but complementary characteristics, allowed a reproducible and standardised investigation of NVD and NVE. The proposed new SS-OCTA cortical vitreous segmentation protocols may be of value when identifying and assessing NV-activity (VRS, OVS and CVS) or NV-regression (VRS) in PDR and therefore, response to therapy.
AB - Purpose: To identify a new cortical vitreous segmentation protocol for non invasive standardised investigation of Neovascularisation (NV) with detection of regression of NV activity in Proliferative Diabetic Retinopathy (PDR). Design: Retrospective study. Participants: One hundred and eighty-six eyes of 93 consecutive diabetic patients (mean age: 52.6 ± 11.0 years) imaged using Topcon Triton® Swept-Source Optical Coherence Tomography Angiography (SS-OCTA) from June 2015 to January 2017. Methods: Scans were performed through the macula, optic disc and areas of possible NV in mid-peripheral retina using 6 × 6 mm and/or 9 × 9 mm raster-patterns in three segmentation protocols: Vitreo-Retinal (VRS), Outer-Vitreous (OVS) and Core-Vitreous Segmentation (CVS). Any suspicion of PDR was confirmed in all patients by Heidelberg® Widefield-Fundus-Fluorescein-Angiography (WF-FFA) and/or Optos® Ultra-WF-FFA (UWF-FFA). Inter-observer reproducibility of NV diagnosis and agreement between SS-OCTA and UWF-FFA were assessed. Primary outcome was the identification of an effective and reproducible segmentation protocol. Secondary outcome was the identification of NV regression after treatment. Results: Sensitivity-specificity reached, respectively, the value of 100 to 100 in detecting NVD, and 96.6 to 100 in detecting NVE in compared areas. SS-OCTA was able to confirm absence of blood flow within the residual NV plexus when using VRS protocol in 30 eyes in which regression of NV with absence of leakage was documented on FFA. Conclusion: Three segmentation protocols (VRS, OVS and CVS) with different but complementary characteristics, allowed a reproducible and standardised investigation of NVD and NVE. The proposed new SS-OCTA cortical vitreous segmentation protocols may be of value when identifying and assessing NV-activity (VRS, OVS and CVS) or NV-regression (VRS) in PDR and therefore, response to therapy.
KW - Diabetes mellitus
KW - diabetic retinopathy
KW - neovascularisation
KW - OCT
KW - OCTA
KW - optical coherence tomography
KW - optical coherence tomography angiography
KW - proliferative diabetic retinopathy
KW - retina imaging
KW - Triton
KW - ultra high-speed swept source optical coherence tomography angiography
KW - vitreous
KW - vitreous segmentation
UR - http://www.scopus.com/inward/record.url?scp=85088842317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088842317&partnerID=8YFLogxK
U2 - 10.1177/1120672120944028
DO - 10.1177/1120672120944028
M3 - Article
C2 - 32722940
AN - SCOPUS:85088842317
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
SN - 1120-6721
ER -